my uncle is getting cancer treatment doctor advises to go for radiations we fear the condition will detoriar?

Question

suggest what should be the line of treatment he is also taking homeopathic drugs we have taken chemotherapy ( he is suffering from lung cancer he has been a smoker)

Answer 1

I'm sorry to hear that your uncle is doing poorly.

It's hard to tell what his prognosis is without more information. Here is a link to more than you probably want to know about lung cancer:
http://www.cancer.gov/cancertopics/types/lung

Homeopathic drugs are given in such low concentrations that they shouldn't interfere with any other treatment.

Good luck.

Answer 2

My father was diagnosed with bone cancer in 2001. He went threw the chemo and the radiation and is now in remission going on five years. If that is the only treatment the doctor feel will help him and he wants to do it then do it. The chemo is a lot worse then the radiation was for my dad. Good luck

Answer 3

Tell the doctor about the homeopathic things he is taking. The radiation is there to help him. I would be more worried about what's in the homeopathic things than about regulated, studied and proven treatment.

Answer 4

Do what the doctor advises, but make sure the doctor also knows about the "homeopathic" drugs because they may be interfaring with the treatment.

Answer 5

Your uncle might tolerate radiation better with Novo Two.

N0V-002 (novo-two) is a New adjunct medication used with standard chemotherapy tested for approval in the USA.

Increased the ability of patients to tolerate Chemo to the full 100%
Increased the Cancer Survival rate by 80%

They are accepting some patients under FDA Fast Track SPA Phase III in the USA.

See "Got the Script" message on this board, it's available outside the USA:

http://messages.finance.yahoo.com/mb/NVLT.OB

Novelos' pipeline of drugs is based on oxidized glutathione, a natural metabolite that is part of the glutathione pathway. This pathway is the primary determinant of intracellular redox (oxidation/reduction) potential and, as such, plays a key role in cell protection (e.g. detoxification) and in regulation of cell signaling pathways (e.g. leading to cytokine production). Novelos’ lead products are believed to act, in part, via post-translational modification (glutathionylation) of critical regulatory proteins that mediate processes including immune function, cell proliferation and tumor progression (in combination with chemotherapy). They may also sensitize tumor cells to certain chemotherapeutic drugs by modifying drug detoxification processes.